Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing.

ALTEX·2025
Same author

A path forward advancing microphysiological systems.

ALTEX·2025
Same author

Is regulatory science ready for artificial intelligence?

NPJ digital medicine·2025
Same author

Ethical principles for regulatory risk decision-making.

Regulatory toxicology and pharmacology : RTP·2025
Same author

Editorial: Leveraging artificial intelligence and open science for toxicological risk assessment.

Frontiers in toxicology·2025
Same author

Editorial: Multisystem inflammatory syndrome observed post-COVID-19: the role of natural products, medicinal plants and nutrients and the use of prediction tools supporting traditional forms of diagnosis.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Jun 16, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Per aspirin ad astra...

Thomas Hartung1

  • 1CAAT, Johns Hopkins University, Baltimore, USA. thartung@jhsph.edu

Alternatives to Laboratory Animals : ATLA
|January 29, 2010
PubMed
Summary
This summary is machine-generated.

Aspirin

Related Experiment Videos

Last Updated: Jun 16, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Area of Science:

  • Toxicology
  • Regulatory Science
  • Drug Safety

Background:

  • The 110th anniversary of aspirin marketing highlights a contrast between its toxicological profile and real-world use.
  • Historical context suggests current regulatory toxicology standards were not applied during aspirin's early marketing.
  • The Three Rs (Replacement, Reduction, Refinement) in animal testing are considered alongside a proposed fourth R: Realism.

Purpose of the Study:

  • To critically evaluate the adequacy of current toxicological tools for future challenges.
  • To assess the feasibility of implementing the EU REACH system with existing toxicological methodologies.
  • To examine whether replacing animal tests individually leads to a fundamentally new toxicology or merely incremental changes.

Main Methods:

  • Comparative analysis of aspirin's historical use and toxicological data.
  • Assessment of current toxicological tools against future challenges.
  • Evaluation of the EU REACH system's implementation feasibility.
  • Analysis of the impact of classical alternative methods on toxicological paradigms.

Main Results:

  • Current toxicological tools are deemed inadequate for emerging challenges.
  • The EU REACH system's implementation faces significant feasibility issues due to throughput limitations of current tools.
  • Replacing animal tests individually (classical alternative methods) does not fundamentally advance toxicology beyond ethical improvements, merely altering existing frameworks.

Conclusions:

  • A paradigm shift in toxicology is necessary, moving beyond incremental changes.
  • Future toxicology requires new approaches, such as evidence-based toxicology and global human toxicology programs.
  • Initiatives like "Toxicology for the 21st Century" offer a promising direction for developing a robust, modern toxicological framework.